ESSO Course on Peritoneal Surface Malignancy
|
|
|
- Myrtle Parker
- 10 years ago
- Views:
Transcription
1 ESSO Course on Peritoneal Surface Malignancy In partnership with The Christie School of Oncology October 2015 MANCHESTER (UK)
2 ESSO Course on Peritoneal Surface Malignancy Chair: Sarah O Dwyer, The Christie NHS Foundation Trust, Manchester, UK Co-Chair: Santiago González-Moreno, MD Anderson Cancer Center, Madrid, SP Faculty Members Thomas Bacheitner- Hofmann, Medical University of Vienna, AT Norman Carr, Basingstoke and North Hampshire Hospital, Basingstoke, UK Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK Marcello Deraco, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT Charles Honoré, Institut de Cancérologie Gustave Roussy, Villejuif, FR Brendan Moran, Basingstoke and North Hampshire Hospital, Basingstoke, UK Pompiliu Piso, St. John of God Hospital, Regensburg, DE Beate Rau,Charité Campus Mitte, Berlin, DE Josefin Segelman, Karolinska Institut, Solna, Stockholm, SE Paul H Sugarbaker, Washington Cancer Center, Washington, USA Kurt Van der Speeten, Ziekenhuis Oost-Limburg, Genk, BE Vic Verwaal, The Netherlands Cancer Institute, Amsterdam, NL Willemien van Driel, Netherlands Cancer Institute, Amsterdam, NL Local Faculty Omar Aziz Rahul Deshpande Paul Fulford Vidya Kasipandian Rohit Kochhar Andrew Renehan Mark Saunders Chelliah Selvasekar Malcolm Wilson
3 Aim of the course A comprehensive workshop on Peritoneal Surface Malignancies addressing current treatments for specific tumour groups and future challenges for developing services in different health care settings. The course will focus on delivering evidence-based clinical practice and achieving quality assured outcomes for patients undergoing abdominal and pelvic cytoreductive surgery and intraperitoneal chemotherapy. Topics covered Neoplasia of the appendix: pathology, diagnosis and clinical pathways Peritoneal Surface Malignancies: outcomes for colorectal, ovarian, gastric cancers and mesothelioma Surgical techniques: tips and tricks to achieve complete cytoreduction Intraperitoneal chemotherapy: why, what, who and how Setting up a service: challenges and opportunities Ideal Course candidates Consultant Surgeons/gynaecologists/oncologists Senior residents/fellows surgery/gynaecology/oncology Senior Nurse Practitioners in PSM/oncology Educational methods Live surgical session with interactive discussion Video sessions/workshops on surgical technique and HIPEC Plenary lectures MDT case management Interactive voting on key topics Course Venue The Christie NHS Foundation Trust Wilmslow Road Manchester, M20 4BX United Kingdom
4 Course coordination Ana Galán European Society of Surgical Oncology (ESSO) . Application Procedure Please go to (education/projects & courses) to complete your application and apply for the course. Participation fee The participation fee is 650 for ESSO members and 800 for non-members. It includes registration for the 2-day course,coffee breaks and lunches and a social dinner. Accreditation An application for accreditation has been submitted to the European Accreditation Council for CME (EACCME) of the European Union of Medical Specialists (UEMS).
5 Programme Thursday 08 October Welcome 08:15-08:30 Aims and objectives; global guidelines S. O Dwyer, S.González-Moreno Generic challenges in PSM Service delivery for PSM Moderators: B. Moran, P. Piso 08:30-08:45 The European picture: reference centres and networks S.González-Moreno 08:45-09:00 Setting up a service: challenges and opportunities T. Bacheitner - Hofman 09:00-09:05 Discussion 09:05-09:35 Imaging for PSM: what the MDT should look for R. Kochar 09:35-09:40 Discussion 09:40-10:10 Keynote address: Evidence base and principles of management of peritoneal metastases P. Sugarbaker Chemotherapy Moderators: A. Renehan, V. Verwaal 10:10-10:25 HIPEC: overview of current regimes K. Van der Speeten 10:25-10:30 Can we reach a consensus: voting 10:30-10:40 Systemic chemotherapy: when how and what M. Saunders 10:40-10:50 EPIC: when how and what K. Van der Speeten 10:50-10:55 Can we reach a consensus: voting 10:55-11:15 Coffee break Perioperative support: tips and tricks Moderators: P. Fulford, T.B- Hofmann 11:15-11:30 Anaesthesia, critical care and pain management V. Kasipandian 11:30-11:45 Nutrition and enhanced recovery O. Aziz 11:45-12:00 Complications: how to avoid them B. Rau 12:00-12:15 Standardised recording of morbidity and mortality A. Reneham
6 12:15-12:30 Recommendations for follow up: why, who and for how long? T. Cecil 12:30-12:45 Discussion/voting Lunch Surgical techniques: tips and tricks Moderators: M. Wilson, S.G. Moreno 13:30-14:30 RUQ, R. Deshpande LUQ, P. Piso Central abdomen, M. Deraco Pelvis, T. Cecil MAS, C. Selvaseker HIPEC, K. Van der Speeten 14:30-14:45 Discussion 14:45-15:00 Coffee break Parallel sessions 15:00-17:00 Surgical techniques workshops/videos MDT case discussions Pathology workshop Nursing workshop Friday 09 October Disease specific challenges in PSM Appendix neoplasia Moderators: P. Fulford, M. Deraco 08:30-08:55 Keynote address: Concensus on the classification of appendix neoplasia N. Carr 08:55-09:00 Discussion 09:00-09:15 PMP Presentation and outcomes M. Wilson 09:15-09:30 Management of recurrence B.Moran 09:30-09:40 Discussion Surgery Moderators: S. O Dwyer, C. Selvaseker, A. Renehan, P. Fulford 09:40-10:15 Case Presentation and Live Surgery Coffee break
7 Colon and rectum Moderator: P. Piso 10:45-11:00 Patient selection and outcomes C. Honore 11:00-11:10 Selecting high risk patients J. Segelman 11:10-11:25 Future opportunities for CRS in colorectal cancer P.Sugarbaker 11:25-11:30 Discussion Surgery 11:30-12:00 Live surgery/ case discusion Mesothelioma Moderator: T. Cecil 12:00-12:40 Keynote address: Current and Future directions for the treatment of Peritoneal Mesothelioma M. Deraco 12:40-12:45 Discussion 12:45-13:45 Lunch (live surgery continues during lunch break) Gastric Cancer Moderator: C. Honore 13:45-14:10 Patient selection outcomes and future potential P. Piso 14:10-14:15 Discussion Surgery 14:15-14:30 Live surgery Ovarian Cancer Moderator: V. Verwaal 14:30-15:00 Keynote adress: Evidence base and recommendations for the treatment of ovarian peritoneal metastasis W. van Driel Discussion Palliative treatment for PSM Moderator: B.Rau 15:05-15:20 Strategies and outcomes from palliation K. Van der Speeten 15:20-15:25 Discussion 15:25-15:50 MDT Case discussions/live surgery update 15:50-16:00 Summary and Close
8 ESSO is grateful for the continuous support of its corporate sponsors European Society of Surgical Oncology (ESSO) Avenue E. Mounier 83 B 1200 Brussels Tel: +32 (0) Fax : +32 (0) [email protected] Website :
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma Focus on stage III and IV melanoma In partnership with the Society of Surgical Oncology (SSO) 12-14 November 2015 ATHENS (GR)
Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation
Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation 06-07 November 2015 MILAN (IT) IN PARTNERSHIP WITH Enhanced Recovery after Surgery: Benefits, Challenges and Solutions
Highly Specialised Services. Peritoneal Oncology Service. Report September 2015
Highly Specialised Services Peritoneal Oncology Service Report September 2015 The Christie NHS Foundation Trust Wilmslow Road Withington Manchester M20 4BX http://www.christie.nhs.uk/our-services/colorectal-and-peritoneal-oncology-centre
ESSO Advanced Course on Oncoplastic Breast Surgery 16-18 June 2016
ESSO Advanced Course on Oncoplastic Breast Surgery 16-18 June 2016 BUDAPEST (HU) ESSO Advanced Course on Oncoplastic Breast Surgery Course directors Tibor Kovacs, Guy s and St. Thomas NHS Foundation Trust,
Luis D. Carcorze Soto, MD PGY-3
Luis D. Carcorze Soto, MD PGY-3 Peritoneal Surface Malignancies Peritoneum Patient Selection Operative Technique HIPEC EPIC Primary: Primary Peritoneal Carcinoma Malignant Peritoneal Mesothelioma Metastatic:
Peritoneal Surface Malignancies. Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA
Peritoneal Surface Malignancies Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA Cancer dissemination routes Hematogenous metastases Lymphatic metastases Implants on peritoneal surfaces Surgically
Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD
Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD KCHC 8/29/13 52 y.o. F presented with severe pain in the right back and right flank, sharp, 8 out of 10, for 7 days.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Mazin Al-kasspooles, MD Associate Professor of Surgery Division of Surgical Oncology Director, Regional Therapy
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
Chirurgia Avanzata Del Carcinoma Ovarico Nuove Strategie A Confronto Ovarian Cancer Advanced Surgery New Strategies in Comparison
Peritoneal dissection and intraperitoneal chemotherapy under hyperthermic conditions. If you select the right patients long-term survival can be achieved. Chirurgia Avanzata Del Carcinoma Ovarico Nuove
ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN. 8-13 March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS
MASTERCLASS Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans 7 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 8-13 March 2014 Ermatingen
Pseudomyxoma Peritonei Where are we in 2014?
Pseudomyxoma Peritonei Where are we in 2014? Santiago González-Moreno, MD, PhD Head, Department of GI Surgical Oncology Peritoneal Surface Oncology Program Medical Director * * * * * * * * * * * * French
Cytoreduction and hyperthermic intraperitoneal chemotherapy for the treatment of pseudomyxoma
Medical Policy Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pseudomyxoma Peritonei and Peritoneal Carcinomatosis of Gastrointestinal Origin, and Peritoneal Mesothelioma
15th Colorectal Day Programme
15th Colorectal Day Programme 7TH OF JUNE 2016 AARHUS UNIVERSITY HOSPITAL, SKEJBY ENTRANCE 6, AUDITORIUM A www.crd.auh.dk Fotograf: Kristian Bang, AUH Dear friends and colleagues It is our pleasure to
GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA. 17-18 June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA 17-18 June 2010 Golnik, Slovenia Chair: T. Cufer, SI - G.L. Ceresoli, IT AIM OF THE COURSE The incidence
Advances in Surgical Oncology
3-4 December 2015 Advances in Surgical Oncology 3 rd International Conference of the Medical University of Lublin 10 th anniversary of first Intraoperative Radiotherapy in Lublin 1 Scientific Chairman
How To Teach A Patient To Live With A Tumour
RECTAL CANCER WHEN TO OPERATE Operative Treatment Strategies... From Minimal to Maximal Champalimaud Foundation Lisbon, Portugal 7 th - 8 th November 2014 Organisation - Champalimaud Foundation Amjad Parvaiz
Quick Facts about Appendix Cancer
Quick Facts about Appendix Cancer What is the appendix? The appendix is a pouch-like tube attached to the first part of the large intestine (cecum). The appendix is about 10 centimetres long and has no
International Symposium on Malignant Pleural Mesothelioma
International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear
Rachel E. Kirby, Jing Zhao, Terence Chua, Winston Liauw and David L. Morris *
Send Orders for Reprints to [email protected] The Open Surgical Oncology Journal, 2014, 5, 1-5 1 Open Access Avoidance of Early Post-Operative Intraperitoneal Chemotherapy (EPIC) Following Peritonectomy
INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)
MEDICAL POLICY INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) Policy Number: CS141.A Effective Date: September 1, 2015 Table of Contents COVERAGE RATIONALE DEFINITIONS... APPLICABLE CODES..
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
Villejuif, Paris, France
SCIENTIFIC PROGRAMME 2014 Preceptorships in oncology Aim This live educational preceptorship aims to highlight the crucial role of the multidisciplinary approach in diagnosis, treatment and management
Corporate Medical Policy
Corporate Medical Policy Hyperthermic Intraperitoneal Chemotherapy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hyperthermic_intraperitoneal_chemotherapy 5/19/2005 3/2016 3/2017
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly
Huang et al. World Journal of Surgical Oncology (2015) 13:262 DOI 10.1186/s12957-015-0682-7 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Cytoreductive surgery and perioperative intraperitoneal chemotherapy
CLINICAL ONCOLOGY MASTERCLASS IN. 25-29 April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME
ESO - LATIN-AMERICAN PROGRAMME MASTERCLASS IN CLINICAL ONCOLOGY 25-29 April 2015 São Paulo, Brazil Chairs: N. Pavlidis, GR - R.A. Stahel, CH Scientific Co-ordinators: M. Aapro, CH - F. Cardoso, PT FOREWORD
National Bowel Cancer Audit Report 2008 Public and Executive Summary
National Bowel Cancer Audit Report 2008 Public and Executive Summary Prepared in association with: Healthcare Quality Improvement Partnership HQIP Association of Coloproctology of Great Britain and Ireland
Clinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma
Clinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma Reference: NHS England B03/P/a 1 Information Reader Box (IRB) to be inserted
Die multimodale Behandlung der Peritonealkarzinose
Die multimodale Behandlung der Peritonealkarzinose Pompiliu Piso Chirurgische Klinik der Universität Regensburg 80 Mio Inhabitans 70.000 new cases CRC/year. Henriettenstiftung Hannover Medizinische Hochschule
Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure
Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure Eddy Cotte, Brigitte Tranchand, Annie-Claude Beaujard, François-Noël
CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES
CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinator: Alex Kartheuser (Colorectal Surgery, Cliniques universitaires St-Luc, UCL) Authors
SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN
SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN Paediatric Hepatology: from basic science to daily practice June 13-16th, 2012 Bordeaux, France Program European Society for Paediatric Gastroenterology,
BOWEL CANCER. The doctor has explained that you have a growth or tumour, in your bowel or rectum and could be cancer.
Patient and Carer Information BOWEL CANCER Please read this leaflet carefully. It is important that you take note of any instructions or advice given. If you have any questions or problems that are not
SKIN MELANOMA. 27-28 September 2006, Istanbul, TR
ESO SEMINARES SKIN MELANOMA 27-28 September 2006, Istanbul, TR Chair: N. Cascinelli, IT - A.M.M. Eggermont, NL - S. Kurul, TR Host Chair: M. Erkisi, TR - F. Tas, TR Co-ordinators: G. Demir, TR - H. Camlica,
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
REPORT ON STOMA SERVICE AND PRACTICE. MM / YY to MM / YY. Name: Title: Centre:
REPORT ON STOMA SERVICE AND PRACTICE MM / YY to MM / YY Name: Title: Centre: 1 Contents 1.0 Introduction 2.0 Aims of the Stoma Care Service 3.0 Clinical Activity 4.0 Cost Saving Measures 5.0 Education
H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md
Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland
National Medical Policy
National Medical Policy Subject: Policy Number: Intraperitoneal Hyperthermic Chemotherapy for Abdominopelvic Cancers NMP346 Effective Date*: June 2007 Updated: November 2014 This National Medical Policy
POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
Columbia University Mesothelioma Applied Research Foundation - 2009 - www.curemeso.org. Mesothelioma Center www.mesocenter.org
Columbia University Mesothelioma Center www.mesocenter.org Multimodal clinical trials, treatment (surgery, radiation, chemotherapy) Peritoneal mesothelioma program Immunotherapy translational, experimental
COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER
COMMISSIONING for ULTRA-RADICAL SURGERY in ADVANCED OVARIAN CANCER WHY THIS MUST HAPPEN PERSPECTIVE COMMISSIONING FOR WHO, FOR WHAT? Biological Basis Surgical Basis International and national standards
How To Manage A Cancer Oncology Clinic
GYNAECOLOGICAL ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY Version 3 Policy agreed Sept 2009 (updated Jan/Feb 2013) Agreed by: SCAN gynae group 2009 Update agreed SCAN gynae group May
How To Treat Mesothelioma
Mesothelioma in the UK Liz Darlison Mesothelioma UK The National Macmillan Mesothelioma Resource Centre June 2010 Mesothelioma Applied Research Foundation - 2010 www.curemeso.org Contents Size of Mesothelioma
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native
IN MANY PATIENTS WITH ABDOMINAL OR PELVIC MALIGNANCIES, surgical treatment
Sugarbaker, Cancerología 3 (2008): 119-124 1 Washington Cancer Institute, Washington, DC, USA Overview of Peritoneal Carcinomatosis Paul H. Sugarbaker 1 Abstract IN MANY PATIENTS WITH ABDOMINAL OR PELVIC
Information for Men Diagnosed with Testicular Cancer
Patient Information Service Information for Men Diagnosed with Testicular Cancer Bristol Haematology and Oncology Centre Bristol Testicular Cancer Service Patient Information is supported by September
Peritoneal Carcinosis
Peritoneal Carcinosis What is it and how to cure it Peritoneum Peritoneum is a thin and transparent membrane that covers the internal part of the abdominal and pelvic cavity and all the viscera contained
Fact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)?
For this reason, some doctors prefer the term borderline ovarian tumour rather than borderline ovarian cancer. Fact sheet 10 Borderline ovarian tumours We, Ovacome, are a support network for people affected
Program Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change
FRIDAY, FEBRUARY 20, 2015 Program Chairs: and Martin Martino, MD Speakers and times are subject to change 6:00 a.m. 6:00 p.m. Registration/Information Desk /L Foyer 6:00 a.m. 6:00 p.m. Speaker Ready Area
Scientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
Gentofte Workshop 2013
Gentofte Workshop 2013 Copenhagen University Hospital Gentofte, Denmark Basic course in CT guided lung biopsy 13th and 14th of June, 2013 Dear colleagues It is a pleasure to invite you to our fourth basic
FRIDAY MAY 9, 2014. Seattle, WA
FRIDAY MAY 9, 2014 ORIN SMITH AUDITORIUM UW Medicine south lake union campus Seattle, WA Course Description This symposium is designed to bring state of the art information on current research and clinical
EMRI ERASMUS COURSE ON MAGNETIC RESONANCE. MRI Abdominal Module
EMRI ERASMUS COURSE ON MAGNETIC RESONANCE MRI Abdominal Module September, 23-26, 2015 Coimbra, Portugal LOCAL ORGANIZERS F Caseiro-Alves L Curvo-Semedo Dear Colleagues: It is our pleasure to receive you
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS Description of Treatment A major difficulty in treating
Treating Mesothelioma - A Quick Guide
Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information
J Clin Oncol 27:6237-6242. 2009 by American Society of Clinical Oncology INTRODUCTION
VOLUME 27 NUMBER 36 DECEMBER 20 2009 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma:
OVARIAN CANCER TREATMENT
OVARIAN CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre National Cancer Plan May 2015 Contents About this booklet 1 The Ovaries
Richmond meets Salzburg
Richmond meets Salzburg A Foregut and Bariatric Surgery Symposium Thursday 10 th till Friday 11 th of December 2015 Salzburg Congress 122 nd educational meeting in cooperation with the Austrian Society
Gentofte Workshop. Gentofte. Hospital 10/2012. University. Training Centre
Gentofte Workshop 10/2012 Gentofte University Hospital EUS and EBUS Training Centre Basic course in interventional endosonography for lung diseases 1st and 2nd October 2012 Dear colleagues, It is a pleasure
Mapping quality assurance approaches in Europe
Mapping quality assurance approaches in Europe Reinhard Busse (with Helena Legido-Quigley & Martin McKee) Professor of Health Care Management, Technische Universität Berlin European Observatory on Health
Clinical Policy Bulletin: Hyperthermia in Cancer Therapy
Hyperthermia in Cancer Therapy Page 1 of 28 Aetna Better Health 2000 Market Street, Suite 850 Philadelphia, PA 19103 AETNA BETTER HEALTH Clinical Policy Bulletin: Hyperthermia in Cancer Therapy Number:
E UROPEAN PERSONAL INFORMATION
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Work Address ARTURO CHITI Humanitas University, Via A. Manzoni 113, 20089 Rozzano (MI), Italy Nuclear Medicine Department, Humanitas Research
Healthcare Management
5-7 May 2015 Gallagher Convention Centre, Midrand, Johannesburg, OFFICIAL CHARITY 2015 Healthcare Management Conference ALL REGISTRATION FEES FROM THE CONFERENCES WILL BE DONATED TO THE STEPS CHARITY 5
How do I find the best place to get treatment for my lymphoma?
Produced November 2010 Next revision due November 2012 How do I find the best place to get treatment for my lymphoma? Introduction Fortunately this is not a question that patients with cancers of the blood
Salisbury Lung Cancer Service (1 of 5)
Salisbury Lung Cancer Service (1 of 5) i If you need this information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 email: customercare@ salisbury.nhs.uk.
Gynaecological Cancers 2015
Gynaecological Cancers 2015 Annex D Epidemiology 1. It is estimated that there will be an increase in the incidence of gynaecological cancers by 2015. For example: a. The incidence of cervical cancer is
British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015
0116 250 2811 [email protected] www.btog.org @BTOGORG British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 BTOG s Aim BTOG is the multi-disciplinary group for professionals
PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology
PRODYNOV Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI Image Assisted Laser Therapy for Oncology Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI
How To Prepare A Meeting For A Health Care Conference
THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App
ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN
D International Symposium: Immunostimulatory monoclonal antibodies and immunomodulation: harvesting the crop Fundación Ramón Areces GENERAL INFORMATION DATES OCTOBER 18th 20th VENUE University of Navarra.
A succesfull case of HIPEC in a peritoneal mesothelioma patient
A succesfull case of HIPEC in a peritoneal mesothelioma patient Firmino, NLJ¹²; Miranda, E¹³; Oliveira, DA ²; Lima, MBA ¹²; Diniz, AF ¹²; Gomes, GES ¹²; Azevedo, LW ¹²; Soares,MC¹²; Gomes, ASA³. ¹Pernambuco
Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface
J. Exp. Clin. Cancer Res., 22, 4, 2003 - Supplement Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface Malignancy Yan T.D., Esquivel J., Carmignani
Professional Managers Annual Conference Adding value to business schools Programme
Professional Managers Annual Conference Adding value to business schools Programme 3-4 December 2015, Regent s University London Professional Managers Annual Conference 2015 - Adding value to business
Please see the LUCADA data manual v3.1.3, available in the downloads section
National Lung Cancer Audit Frequently Asked Questions What dataset should be used? Please see the LUCADA data manual v3.1.3, available in the downloads section What does LUCADA stand for? LUCADA stands
FAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON. 19-20 May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H.
INSIDE TRACK CONFERENCE ESO, CNIO AND NRCO CONFERENCE ON FAMILIAL CANCER 19-20 May 2016 Madrid, Spain Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H. Vasen, NL FOREWORD The ESO, CNIO and NRCO Conference
Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma
Original Article 291 Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma Grace HC Tan, 1 MBBS (London), MRCS (Edinburgh), Michelle Cheung, 1 MBBCh
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA
Guideline for the Follow Up of Patients Following Treatment for Breast Cancer
Guideline for the Follow Up of Patients Following Treatment for Breast Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Page 1 of 6 1 Scope of the Guideline This guideline
Bristol Hospital Cancer Care Center 2015 Annual Report
Bristol Hospital Cancer Care Center 2015 Annual Report 2015 Annual Report Cancer Care Center At every point along the path, our team is there, keeping the focus on the most important team member - the
Minimally Invasive Cardiac Surgery
3rd Annual Bakken Symposium Minimally Invasive Cardiac Surgery December 7 & 8, 2009 Mayo Auditorium, COURSE DIRECTORS: Kenneth K. Liao, MD, PhD James D. St. Louis, MD Presented by Department of Surgery
ONDON. Complications in Spine Surgery An International Educational Training Program. Course Chairmen: 5-6 June, 2015 London, UK
Complications in Spine Surgery An International Educational Training Program 5-6 June, 2015 London, UK Hilton London Paddington Hotel Course Chairmen: Professor Rune Hedlund, MD, PhD Choll Kim, MD, PhD
PREPARING FOR YOUR STOMA REVERSAL
PREPARING FOR YOUR STOMA REVERSAL Information Leaflet Your Health. Our Priority. Page 2 of 6 Introduction- What you need to know As part of your bowel operation you may have had a temporary stoma formed.
